Maldonado, 12 patient HCQ late treatment study: 91% lower mortality [p=0.17] https://c19p.org/maldonado
copied to clipboard
COVID-19 incidence and outcomes in a home dialysis unit in Madrid (Spain) at the height of the pandemic
et al., Nefrología, doi:10.1016/j.nefro.2020.09.002
Very small retrospective of 12 dialysis patients showing 1/11 deaths with HCQ and 1/1 without HCQ.
|
risk of death, 90.9% lower, RR 0.09, p = 0.17, treatment 1 of 11 (9.1%), control 1 of 1 (100.0%), NNT 1.1.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
treatment or control group size extremely small.
Maldonado et al., 11/5/2020, retrospective, Spain, Europe, peer-reviewed, 10 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.